SBIR-STTR Award

Real-Time Fluorescence-Activated Renal Monitor
Award last edited on: 6/16/08

Sponsored Program
STTR
Awarding Agency
NIH : NIDDK
Total Award Amount
$784,417
Award Phase
2
Solicitation Topic Code
-----

Principal Investigator
Carlos Rabito

Company Information

Diametrx Inc

1 Arcadia Road
Natick, MA 01760
   (508) 652-9999
   N/A
   N/A

Research Institution

Massachusetts General Hospital

Phase I

Contract Number: 1R42DK055964-01
Start Date: 00/00/00    Completed: 00/00/00
Phase I year
2000
Phase I Amount
$140,731
Real-time and accurate data of the renal function are needed to develop new approaches for the prevention and treatment of acute renal failure (ARF). Current techniques have neither the accuracy nor the resolution time required. A highly innovative approach, was recently developed for the real-time and accurate measurement of glomerular filtration rate (GFR). The technique determines, minute-to-minute, the rate of disappearance from the extracellular space (ES) of a radiolabeled GFR agent as measured with an external radioactivity counting device. Although the approach showed excellent results, the use of radioactivity, limit its application. As an alternative, this project proposes the use a GFR agent labeled with a laser fluorescent dye (FGFR). The project involves the synthesis of the agent, the design and assembly of an instrument to measure the laser-induced tissue fluorescence (LITF) and the initial validation of the technique in rats. The synthesis of the agent will be performed by labeling with a laser fluorescent dye a well established GFR agent. A laser photodiode will be used in the instrument for the excitation beam. The LITF will be measured and recorded for further processing. At a constant excitation, LITF should be proportional to the tissue concentration of FGFR. This concept will be validated in rats by comparing the LITF with direct tissue concentration after extraction of the dye. This alternative method should represent a significant advance, not only for immediate detection of renal dysfunction to avert ARF, but also for the instant evaluation of the response to therapy in patients with ARF. PROPOSED COMMERCIAL APPLICATION: NOT AVAILABLE

Public Health Relevance:
This Public Health Relevance is not available.

Thesaurus Terms:
Acute Renal Failure, Biomedical Equipment Development, Fluorescent Dye /Probe, Glomerular Filtration Rate, Patient Monitoring Device Chemical Synthesis Laboratory Rat

Phase II

Contract Number: 4R42DK055964-02
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
2001
(last award dollars: 2002)
Phase II Amount
$643,686

Real-time and accurate data of the renal function are needed to develop new approaches for the prevention and treatment of acute renal failure (ARF). Current techniques have neither the accuracy nor the resolution time required. A highly innovative approach, was recently developed for the real-time and accurate measurement of glomerular filtration rate (GFR). The technique determines, minute-to-minute, the rate of disappearance from the extracellular space (ES) of a radiolabeled GFR agent as measured with an external radioactivity counting device. Although the approach showed excellent results, the use of radioactivity, limit its application. As an alternative, this project proposes the use a GFR agent labeled with a laser fluorescent dye (FGFR). The project involves the synthesis of the agent, the design and assembly of an instrument to measure the laser-induced tissue fluorescence (LITF) and the initial validation of the technique in rats. The synthesis of the agent will be performed by labeling with a laser fluorescent dye a well established GFR agent. A laser photodiode will be used in the instrument for the excitation beam. The LITF will be measured and recorded for further processing. At a constant excitation, LITF should be proportional to the tissue concentration of FGFR. This concept will be validated in rats by comparing the LITF with direct tissue concentration after extraction of the dye. This alternative method should represent a significant advance, not only for immediate detection of renal dysfunction to avert ARF, but also for the instant evaluation of the response to therapy in patients with ARF. PROPOSED COMMERCIAL APPLICATION: NOT AVAILABLE

Public Health Relevance:
This Public Health Relevance is not available.

Thesaurus Terms:
Acute Renal Failure, Biomedical Equipment Development, Fluorescent Dye /Probe, Glomerular Filtration Rate, Patient Monitoring Device Chemical Synthesis Laboratory Rat